Sight Sciences (SGHT) Operating Income (2020 - 2026)
Sight Sciences (SGHT) posted Operating Income of -$3.9 million for Q2 2026, up 68.68% on a QoQ basis from -$12.4 million in Q1 2026, and up 66.68% year-over-year from -$2.3 million in Q2 2025.
Analysis
Sight Sciences (SGHT) Operating Income (2020 - 2026) Analysis & Trends
Sight Sciences has reported Operating Income for 7 years, with the latest figure at -$3.9 million in Q2 2026.
- On a quarterly basis, Operating Income rose 66.68% year-over-year to -$3.9 million in Q2 2026; TTM through Jun 2026 was -$27.9 million, a 42.74% increase from a year earlier, with the FY2025 full-year figure at -$37.1 million, up 26.58% from the prior year.
- Operating Income was -$3.9 million for Q2 2026 at Sight Sciences, up from -$12.4 million in the prior quarter.
- The five-year high for Operating Income was -$3.7 million in Q4 2025, with the low at -$22.9 million in Q2 2022.
- Average Operating Income over 5 years is -$13.6 million, with a median of -$13.0 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Operating Income plunged 106.43% in 2022, then surged 69.24% in 2025.
- Over 5 years, Operating Income stood at -$17.1 million in 2022, then jumped by 34.85% to -$11.1 million in 2023, then declined by 7.37% to -$11.9 million in 2024, then soared by 69.24% to -$3.7 million in 2025, then fell by 5.97% to -$3.9 million in 2026.
- The last three Operating Income figures came in at -$3.9 million (Q2 2026), -$12.4 million (Q1 2026), and -$3.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.42 Bn | 178.82 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Intuitive Surgical | 124.16 Bn | 118.94 Bn | 1.96 Bn | 971.90 Mn |
| 3 | Medtronic | 118.41 Bn | 109.59 Bn | 6.34 Bn | 1.76 Bn |
| 4 | Stryker | 104.45 Bn | 100.98 Bn | 4.50 Bn | 1.66 Bn |
| 5 | Boston Scientific | 66.47 Bn | 65.93 Bn | 3.85 Bn | 1.18 Bn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.46 Bn | 1.35 Bn | 513.20 Mn |
| 7 | Alcon | 33.95 Bn | 32.50 Bn | 1.68 Bn | 11.00 Mn |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn | 318.30 Mn |
| 9 | Steris | 21.17 Bn | 20.68 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Sight Sciences | 443.68 Mn | 363.92 Mn | 21.37 Mn | -3.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.89 Mn |
| Mar 31, 2026 | -12.41 Mn |
| Dec 31, 2025 | -3.67 Mn |
| Sep 30, 2025 | -7.91 Mn |
| Jun 30, 2025 | -11.67 Mn |
| Mar 31, 2025 | -13.86 Mn |
| Dec 31, 2024 | -11.93 Mn |
| Sep 30, 2024 | -11.23 Mn |
| Jun 30, 2024 | -12.65 Mn |
| Mar 31, 2024 | -14.72 Mn |
| Dec 31, 2023 | -11.11 Mn |
| Sep 30, 2023 | -13.41 Mn |
| Jun 30, 2023 | -15.19 Mn |
| Mar 31, 2023 | -17.57 Mn |
| Dec 31, 2022 | -17.05 Mn |
| Sep 30, 2022 | -21.85 Mn |
| Jun 30, 2022 | -22.86 Mn |
| Mar 31, 2022 | -22.19 Mn |
| Dec 31, 2021 | -14.72 Mn |
| Sep 30, 2021 | -14.03 Mn |